InflaRx NV (IFRX) Reports First Patient Treatment in Phase IIa Clinical Trial with Lead Candidate IFX-1 in Pyoderma Gangraenosum – StreetInsider.com

InflaRx NV (IFRX) Reports First Patient Treatment in Phase IIa Clinical Trial with Lead Candidate IFX-1 in Pyoderma Gangraenosum – StreetInsider.com

InflaRx NV (IFRX) Reports First Patient Treatment in Phase IIa Clinical Trial with Lead Candidate IFX-1 in Pyoderma Gangraenosum – StreetInsider.com
Published on 2019-06-13